GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Cryo Cell International
Cryo-Cell is a pioneer and leader in the cord blood stem cell banking market. Its stock price reflects both the stability of this business, based on long-term contracts, and the hopes for the future application of stem cells in regenerative medicine.
Share prices of companies in the market segment - Stem_cells
Cryo-Cell International is a pioneer and leader in the cord blood stem cell banking market, providing biobanking services for families. We've categorized it under "Stem Cells." The chart below shows how the market values companies in the regenerative medicine sector.
Broad Market Index - GURU.Markets
Cryo-Cell International is one of the world's first and largest companies providing cord blood stem cell banking services. As a component of the GURU.Markets index, it represents the regenerative medicine sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
CCEL - Daily change in the company's share price Cryo Cell International
For Cryo-Cell International, Inc., a stem cell bank, daily volatility reflects sensitivity to demographic trends and demand for cord blood banking services. This metric is an indicator of the state of the bioinsurance market.
Daily change in the price of a set of shares in a market segment - Stem_cells
Cryo-Cell International, Inc. is a stem cell bank. This chart shows the average daily volatility of the healthcare sector. Comparison with CCEL's performance, which is driven by demographic trends, helps us assess it as a stable, non-cyclical business.
Daily change in the price of a broad market stock, index - GURU.Markets
Cryo-Cell International is a pioneer in cord blood stem cell banking. The company's business operates at the intersection of medicine and family services. Its stock price reflects both demographic trends and scientific advances in regenerative medicine.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Cryo Cell International
Cryo-Cell International's year-over-year performance tells the story of its operations in the cord blood stem cell banking market. Its market capitalization growth over the past 12 months reflects its stable business, based on long-term contracts with parents, as well as its growth potential through the development of therapeutic applications for these cells.
Annual dynamics of market capitalization of the market segment - Stem_cells
Cryo-Cell International, Inc. is a pioneer and leader in cord blood stem cell banking. Its business is based on long-term storage contracts. The graph shows how demographic trends and its efforts to develop new cell therapies influence its stable growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cryo-Cell, a stem cell storage company, operates in the protection business. Demand for its services is driven by demographics (birth rates), not the economy. The company's stock price reflects this predictability, making it less volatile than the overall market and less susceptible to strong economic fluctuations.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Cryo Cell International
Cryo-Cell International is a leader in stem cell storage. Its monthly growth reflects the stability of its business model, based on long-term contracts. Key factors include the pace of new customer acquisition and news about new therapeutic applications for stem cells.
Monthly dynamics of market capitalization of the market segment - Stem_cells
Cryo-Cell International is a pioneer in the field of cord blood stem cell banking. This biobanking sector is driven by demographic trends and public confidence in the future of regenerative medicine. The chart below shows how investors assessed the long-term prospects of preserving biological material for future generations.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cryo-Cell International is a pioneer in cord blood stem cell banking. Its business is built on long-term contracts and demographic trends. Its stock price reflects both the stability of this business and the potential for stem cell use in future medicine.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Cryo Cell International
Cryo-Cell International is one of the world's oldest private stem cell banks. Its weekly stock price reflects demographic trends, scientific breakthroughs in cell therapy that enhance the value of its services, and the company's overall marketing success in attracting clients.
Weekly dynamics of market capitalization of the market segment - Stem_cells
Cryo-Cell International is one of the world's oldest private stem cell banks. Its weekly stock price reflects demographic trends, scientific breakthroughs in cell therapy that enhance the value of its services, and the company's overall marketing success in attracting clients.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cryo-Cell, a stem cell bank, operates a business that is unaffected by economic cycles. Comparing its weekly performance with the broader market will highlight its defensive properties. The chart shows how the company's shares demonstrate stability during periods of market volatility, confirming its unique status.
Market capitalization of the company, segment and market as a whole
CCEL - Market capitalization of the company Cryo Cell International
Cryo-Cell's market capitalization tells the story of the cord blood stem cell banking business. Its chart reflects both the stability of this niche market and the company's efforts to leverage its expertise to develop therapeutic applications for stem cells. It's a visualization of the intersection of services and biotechnology.
CCEL - Share of the company's market capitalization Cryo Cell International within the market segment - Stem_cells
Cryo-Cell International is one of the oldest companies banking cord blood stem cells. Its market capitalization reflects its dominance in this niche. The chart below shows the stability of its business and how investors assess its potential in cell therapy.
Market capitalization of the market segment - Stem_cells
Cryo-Cell International is one of the oldest and largest cord blood stem cell banks in the world. The chart below shows the overall market capitalization of the stem cell industry. Its dynamics reflect both the current use of stem cells in medicine and the hopes for their future application in regenerative therapy.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows a business for the future. Cryo-Cell International is one of the oldest and largest cord blood stem cell banks. Its capitalization is a bet that these cells will be key to treating many diseases in the future. It's an investment in the potential of regenerative medicine.
Book value capitalization of the company, segment and market as a whole
CCEL - Book value capitalization of the company Cryo Cell International
Cryo-Cell's foundation is its laboratory and cryogenic storage facilities where umbilical cord blood stem cells are stored. The book value reflects the value of this unique medical infrastructure. The chart shows how this pioneer in this field manages its capital, providing a "biological insurance" service for thousands of families.
CCEL - Share of the company's book capitalization Cryo Cell International within the market segment - Stem_cells
Cryo-Cell International is a pioneer in cord blood stem cell banking. Its primary asset is a high-tech, secure cryogenic laboratory. The chart shows the company's share of this unique and vital physical infrastructure.
Market segment balance sheet capitalization - Stem_cells
Stem cell storage, as the BCap_Ges chart shows, is a uniquely capital-intensive business. Cryo-Cell International owns cryogenic storage facilities, which are its core and critical physical assets. It's a trust-based business, backed by a robust infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Cryo-Cell International's assets include not only its laboratories but also the largest private stem cell bank, storing hundreds of thousands of samples in specialized cryogenic facilities. Its value reflects the physical scale of this unique "library of life," the material foundation for future regenerative medicine.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Cryo Cell International
Cryo-Cell International is a pioneer in cord blood stem cell banking. Its book value is derived from its laboratories and storage facilities. Its market valuation, via MvsBCap, includes the value of its brand, reputation, and potential for developing regenerative medicine. The chart below shows how investors view the future of this business.
Market to book capitalization ratio in a market segment - Stem_cells
Cryo-Cell International is one of the oldest stem cell storage companies. Its value lies in its brand, reputation, and customer base. The chart shows how the market perceives its market leadership and the stability of its business model.
Market to book capitalization ratio for the market as a whole
Cryo-Cell International is a pioneer in cord blood stem cell banking. Its business combines medical technology and long-term services. Its market valuation reflects both the value of its storage facilities and the value of its brand and customer trust in this highly personal and important matter.
Debts of the company, segment and market as a whole
CCEL - Company debts Cryo Cell International
Cryo-Cell, a pioneer in cord blood stem cell banking, uses capital to market its services and research applications for these cells. This business requires customer trust and ongoing investment to maintain high standards. This chart illustrates the company's financial strategy in this unique biobanking niche.
Market segment debts - Stem_cells
Cryo-Cell International is a pioneer in cord blood stem cell banking. This business requires investment in laboratories, marketing, and maintaining the highest quality standards. This chart shows how the company finances its operations and how its financial model compares to other players in the biobanking market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Cryo Cell International
Cryo-Cell International, a pioneer in stem cell storage, operates at the intersection of medicine and services. This chart shows how the company manages its financial obligations. Debt levels can impact its ability to invest in new cryopreservation technologies and marketing to attract expectant parents.
Market segment debt to market segment book capitalization - Stem_cells
Cryo-Cell International is a pioneer in cord blood stem cell banking. The chart shows the overall debt burden in the sector. It helps assess how the company manages its unique business, based on long-term storage of biomaterials, and how its financial structure reflects the stability and long-term nature of its services.
Debt to book value of all companies in the market
Cryo-Cell International is one of the first and largest companies in the world providing cord blood stem cell banking services. This graph, which shows the financial health of a population, is important for business. The decision to purchase a costly stem cell banking service often depends on financial security and the stability of a family's income.
P/E of the company, segment and market as a whole
P/E - Cryo Cell International
For Cryo-Cell International, a pioneer in stem cell banking, this chart shows the market's valuation of its established business. The trend reflects expectations for the number of new cord blood banking customers and confidence in the future potential of these cells in regenerative medicine.
P/E of the market segment - Stem_cells
This chart shows the average P/E valuation for the biotech sector, of which Cryo-Cell is a veteran. This metric serves as a benchmark for how the market views the established stem cell banking business and its future potential in regenerative medicine.
P/E of the market as a whole
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. The company offers families the opportunity to preserve these cells for potential future medical use. This chart shows the current sentiment in the healthcare sector. It helps understand how the market views the long-term potential of cell therapy and the business model based on long-term storage.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Cryo Cell International
Cryo-Cell International is a pioneer in cord blood stem cell banking. Its business is based on long-term contracts with parents. This chart reflects analysts' predictions regarding demographic trends and families' desire to invest in bioinsurance for the future by preserving their children's stem cells.
%20P%2FE%20Cryo%20Cell%20International&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Cryo-Cell-International&v=1772654686726 "Chart of the company's future (projected) P/E Cryo Cell International")
Future (projected) P/E of the market segment - Stem_cells
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. This chart shows how its future revenue expectations compare to the industry average. Does this valuation reflect its stable business and the potential for future stem cell applications in regenerative medicine?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Stem_cells&v=1772654686752 "Future (projected) P/E graph of the market segment - Stem_cells")
Future (projected) P/E of the market as a whole
Cryo-Cell International is a pioneer in stem cell banking. It's a business built on a long-term vision and customer trust. Given the overall market sentiment shown by this chart, Cryo-Cell can be viewed as a company operating at the intersection of healthcare and consumer services, with a very long lifecycle.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772654686811 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Cryo Cell International
Cryo-Cell International is a pioneer in cord blood stem cell banking. The company's profitability depends on the number of new clients signing long-term storage contracts and on stable payments from its existing customer base. This chart shows how awareness of the potential of cellular medicine is impacting this niche yet stable business.
Profit of companies in the market segment - Stem_cells
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. The company provides biobanking services for families. This chart shows the overall profitability of the biotech services sector, which is growing thanks to increased awareness of the potential of regenerative medicine and parents' desire to preserve this valuable resource.
Overall market profit
Cryo-Cell International is a pioneer in cord blood stem cell banking. This is a one-time purchase decision for parents. Demand for it depends on the birth rate and, more importantly, the disposable income of young families, which is closely linked to the overall economic situation, as reflected in the graph.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Cryo Cell International
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. The company offers families a form of "biological insurance." This chart reflects analysts' expectations for the growth of this market, which depends on demographics and awareness of the potential of cellular medicine.
%20profit%20of%20the%20company%20Cryo%20Cell%20International&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Cryo-Cell-International&v=1772654686972 "Graph of future (projected) profit of the company Cryo Cell International")
Future (predicted) profit of companies in the market segment - Stem_cells
Cryo-Cell International is one of the oldest and largest companies in the world providing cord blood stem cell banking services. The company offers families the opportunity to preserve valuable biological material for future medical use. This chart shows profitability projections for the healthcare sector, reflecting interest in regenerative medicine and cellular technologies.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Stem_cells&v=1772654686985 "Graph of future (predicted) profits of companies in a market segment - Stem_cells")
Future (predicted) profit of the market as a whole
Cryo-Cell International is a pioneer in cord blood stem cell banking. This business relies on demographic trends and the discretionary income of young families. The projected total return shown in the graph provides an indication of the overall economic confidence families need to make this long-term investment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772654686993 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Cryo Cell International
Cryo-Cell International is a pioneer in cord blood stem cell banking. This chart shows how the market values its unique services. The ratio reflects the stability of its business, based on long-term contracts, and its belief in the future of cellular medicine.
P/S market segment - Stem_cells
Cryo-Cell International, Inc. is a pioneer and leader in cord blood stem cell banking. This chart shows the average revenue estimate in the biotech and healthcare sectors. It provides insight into investor perceptions of Cryo-Cell's business model, based on long-term storage of biomaterials, and its potential in regenerative medicine.
P/S of the market as a whole
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. The company offers parents the opportunity to preserve their children's biological material for future medical use. This chart helps understand how the market values this unique business, which sits at the intersection of medicine, biotechnology, and family services.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Cryo Cell International
Cryo-Cell International is a pioneer in cord blood stem cell banking. Its estimated future revenue, shown in the graph, depends on the number of new customers signing long-term storage contracts and the potential future use of these cells in regenerative medicine, which provides the business with long-term value.
%20P%2FS%20Cryo%20Cell%20International&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Cryo-Cell-International&v=1772654687077 "The graph of the company's future (projected) P/S Cryo Cell International")
Future (projected) P/S of the market segment - Stem_cells
Cryo-Cell International is one of the oldest and largest cord blood stem cell banking companies. It provides cryopreservation services to families wishing to preserve these precious cells for the future. This chart shows how investors value its unique service business compared to the biotech sector.
%20P%2FS%20market%20segment%20graph%20-%20Stem_cells&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Stem_cells&v=1772654687100 "Future (projected) P/S market segment graph - Stem_cells")
Future (projected) P/S of the market as a whole
Cryo-Cell International is a pioneer in cord blood stem cell banking. This graph, reflecting overall consumer confidence, influences demand for its services. The decision to bank stem cells is a long-term investment in family health, and people are more willing to make it when they feel economically stable and confident about the future.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772654687133 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Cryo Cell International
Cryo-Cell International is one of the world's first and largest companies banking umbilical cord blood stem cells. This chart shows revenue, which consists of initial fees for collection and processing, as well as annual storage fees. Growth here reflects both the number of new customers and the stability of revenue from the existing base.
Sales of companies in the market segment - Stem_cells
Cryo-Cell International, Inc. is one of the oldest and largest stem cell banking companies in the world. Its business is divided into two main segments: private banking (cord blood banking for families) and processing services for public banks. This chart shows revenue from one of these segments, reflecting the demand for bioinsurance.
Overall market sales
Cryo-Cell International is one of the oldest companies banking umbilical cord blood stem cells. This business is built on parents' desire to provide "biological insurance" for their children. Demand for its services reflects both demographic trends and awareness of the potential of cellular medicine, which is part of the economy of the future.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Cryo Cell International
Cryo-Cell International is one of the oldest and largest cord blood stem cell banking companies in the world. Its revenue forecast depends on the number of new clients signing storage contracts and the stability of its existing client base. It reflects demographic trends and parents' awareness of the value of this bioinsurance.
%20sales%20of%20the%20company%20Cryo%20Cell%20International&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Cryo-Cell-International&v=1772654687235 "Schedule of future (projected) sales of the company Cryo Cell International")
Future (projected) sales of companies in the market segment - Stem_cells
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. This chart reflects expectations for the entire stem cell sector. It helps assess the growing awareness of the potential of cell therapy and the demand for biobanking services analysts predict, driving the entire industry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Stem_cells&v=1772654687261 "Schedule of future (projected) sales of companies in the market segment - Stem_cells")
Future (projected) sales of the market as a whole
Cryo-Cell International, a pioneer in cord blood stem cell banking, says demand for this service depends on the birth rate and financial well-being of young families. This graph of overall sales forecasts is an indicator of consumer confidence, which influences these long-term decisions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772654687300 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Cryo Cell International
Cryo-Cell International is one of the oldest cord blood stem cell banking companies in the world. Its business model is based on upfront processing fees and annual storage fees. This chart shows how these recurring revenues from long-term contracts translate into a stable profit stream.
Market segment marginality - Stem_cells
Cryo-Cell International is a pioneer in cord blood stem cell banking. Profitability in this business depends on the cost of customer acquisition and the effectiveness of long-term storage of the biomaterial. The chart demonstrates the sustainability and profitability of their business model, based on a unique service.
Market marginality as a whole
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. Its business model is based on long-term storage contracts. This chart shows overall profitability, but for CCEL, growing awareness of the potential of stem cells and demographic factors ensure stable demand for its services.
Employees in the company, segment and market as a whole
Number of employees in the company Cryo Cell International
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. This chart shows a stable team of laboratory technicians and consultants. This stable staff reflects the maturity of the business model, based on long-term storage contracts and high customer trust.
Share of the company's employees Cryo Cell International within the market segment - Stem_cells
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. This business requires laboratory technicians, consultants, and marketing specialists. This figure reflects its long-standing presence and scale as an employer in the biobanking industry.
Number of employees in the market segment - Stem_cells
Cryo-Cell International is a pioneer and leader in cord blood stem cell banking. This chart shows employment in the stem cell sector. The growing number of specialists in this field reflects the expanding use of stem cells in regenerative medicine and increased parental awareness of the importance of preserving this valuable biomaterial.
Number of employees in the market as a whole
Cryo-Cell International is one of the oldest stem cell banks. Demand for its services depends on demographics and awareness of the potential of cellular medicine. This long-term trend provides the company with stability, less dependent on short-term economic fluctuations, as reflected in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Cryo Cell International (CCEL)
Cryo-Cell International, Inc. is one of the largest stem cell banks. This business is capital-intensive (cryostorage facilities), but also requires qualified personnel. The moderately high capitalization per employee in this chart reflects the cost of both the technological infrastructure and the customer trust that is built over years.
%20of%20the%20company%20Cryo%20Cell%20International%20(CCEL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Cryo-Cell-International-CCEL&v=1772654687484 "Chart of market capitalization per employee (in thousands of dollars) of the company Cryo Cell International (CCEL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Stem_cells
Cryo-Cell International is one of the oldest cord blood stem cell banking companies. In this business, which combines medicine and long-term services, the cost per employee reflects the value of its customer base and brand. How effectively does the company monetize customer trust and its technological processes?
%20by%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Stem_cells&v=1772654687541 "Market capitalization per employee (in thousands of dollars) by market segment - Stem_cells")
Market capitalization per employee (in thousands of dollars) for the overall market
Cryo-Cell International is a pioneer in cord blood stem cell banking. Their business provides bioinsurance services for families. The chart reflects the market's valuation of this company, which operates at the intersection of medicine, biotechnology, and long-term care.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772654687577 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Cryo Cell International (CCEL)
Cryo-Cell International is one of the oldest and largest cord blood banks. They provide stem cell collection and cryogenic storage services for families. It's a service business with recurring revenue. This chart shows how effectively their laboratories and sales team can attract new clients and service existing ones, generating revenue from long-term storage contracts.
%20Chart%20Cryo%20Cell%20International%20(CCEL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Cryo-Cell-International-CCEL&v=1772654687581 "Company Profit Per Employee (in thousands of dollars) Chart Cryo Cell International (CCEL)")
Profit per employee (in thousands of dollars) in the market segment - Stem_cells
Cryo-Cell International is one of the oldest cord blood stem cell banking companies. It's a service business in the biotech industry, where reputation and laboratory operational efficiency are crucial. This chart shows how efficiently their team generates revenue, which is a measure of the quality of their business model compared to their competitors.
%20in%20the%20market%20segment%20-%20Stem_cells&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Stem_cells&v=1772654687594 "Chart of profit per employee (in thousands of dollars) in the market segment - Stem_cells")
Profit per employee (in thousands of dollars) for the market as a whole
Cryo-Cell (CCEL) is one of the oldest stem cell (cord blood) banks. It's a service business. Its profit per employee is the balance between revenue from new clients (collections) and stable revenue from sample storage. The graph shows how effectively the company manages its laboratories and sales team.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772654687635 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Cryo Cell International (CCEL)
Cryo-Cell International is a pioneer in cord blood stem cell storage. This chart demonstrates the effectiveness of its service model. Stable revenue per employee is generated through annual storage fees from tens of thousands of clients, creating a predictable cash flow.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Cryo-Cell-International-CCEL&v=1772654687643 "Sales chart per company employee Cryo Cell International (CCEL)")
Sales per employee in the market segment - Stem_cells
Cryo-Cell International is one of the oldest and largest stem cell banks. They store cord blood for future medical use. This chart compares Cryo-Cell's revenue per employee to the industry average. This demonstrates how productive their model (collection + long-term storage) is.
Sales per employee for the market as a whole
Cryo-Cell International (CCEL) is a pioneer in the cord blood stem cell banking business (a private biobank). It's a service business: they receive a collection fee and an annual storage fee. This chart shows the storage revenue generated by their laboratory and administrative staff per employee.
Short shares by company, segment and market as a whole
Shares shorted by company Cryo Cell International (CCEL)
Cryo-Cell (CCEL) is one of the oldest private stem cell banks (umbilical cord blood). This business faces both ethical issues and competition. Moreover, the practical applications of these cells are still limited. This chart shows the number of investors who believe this business model has very limited growth potential.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Cryo-Cell-International-CCEL&v=1772654687697 "Short Shares Chart for the Company Cryo Cell International (CCEL)")
Shares shorted by market segment - Stem_cells
Cryo-Cell International is one of the oldest stem cell banks. They offer services for the collection and cryogenic storage of umbilical cord blood stem cells for future medical use. This chart shows the odds against the stem cell banking sector. It reflects concerns about competition and doubts about the widespread therapeutic applications of these cells.
Shares shorted by the overall market
Cryo-Cell International is a cord blood stem cell bank. This is a "future" service paid for from discretionary income. This graph shows the rise in general anxiety. When young families fear for their jobs and income, they may refuse this expensive but optional service, which will reduce the influx of new clients.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Cryo Cell International (CCEL)
Cryo-Cell International is one of the oldest cord blood stem cell banks. Its business depends on the number of newborns and marketing efforts to persuade parents to preserve their cells. This indicator shows how the market reacts to customer growth reports, reflecting "overbought" (above 70) or "oversold" (below 30) conditions in this niche industry.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Cryo-Cell-International-CCEL&v=1772654687797 "RSI 14 indicator chart for the company's stock Cryo Cell International (CCEL)")
RSI 14 Market Segment - Stem_cells
Cryo-Cell International is one of the oldest companies in the world providing cord blood stem cell banking services. It offers "biological insurance" for families. This chart tracks the collective sentiment in the niche stem cell banking sector. It helps us understand whether CCEL's dynamics reflect its unique business model or the general overheating of the regenerative medicine sector.
RSI 14 for the overall market
Cryo-Cell (CCEL) sells "biological insurance"—stem cell storage. This chart is an indicator of confidence. In a euphoric mood, young parents feel wealthy and willing to pay for this "luxury." In times of panic and recession, when mortgage payments are due, this "optional" service is the first to be abandoned.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CCEL (Cryo Cell International)
Cryo-Cell International is one of the oldest private cord blood stem cell banks. This chart shows the average analyst forecast. Their targets are based on the growth of new clients (cell banking), service pricing, and the potential for using these cells in regenerative medicine.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CCEL-Cryo-Cell-International&v=1772654687873 "A chart showing analyst consensus forecasts for the expected stock price. CCEL (Cryo Cell International)")
The difference between the consensus estimate and the actual stock price CCEL (Cryo Cell International)
Cryo-Cell is one of the world's oldest and largest cord blood banks. The company stores stem cells for future medical use. This chart measures the gap between the current price and the consensus target price. It shows how much confidence experts have in this business model and their new therapeutic technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CCEL-Cryo-Cell-International&v=1772654687899 "A chart showing the difference between the consensus forecast and the actual stock price. CCEL (Cryo Cell International)")
Analyst consensus forecast for stock prices by market segment - Stem_cells
Cryo-Cell International is one of the oldest cord blood banks. The company stores newborn stem cells as "bio-insurance" for the future. This chart shows general expectations for the stem cell sector. It reflects whether experts believe the private stem cell banking market will grow.
Analysts' consensus forecast for the overall market share price
Cryo-Cell International is one of the world's first and largest stem cell banks. The company provides services for the collection and storage (freezing) of newborn cord blood "just in case." This chart shows the overall market sentiment. For Cryo-Cell, whose business is a long-term subscription (storage), the overall optimism is important, but their business is also valued for its stable, predictable revenue.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Cryo Cell International
Cryo-Cell is a stem cell bank. Their core business is the collection and cryogenic storage (freezing) of stem cells from newborn cord blood for emergencies (with a paid subscription). This chart is a summary indicator of their sticky business. It reflects their ability to attract new parents (sales) and their stable, high-margin income from storage rentals.
AKIMA Market Segment Index - Stem_cells
Cryo-Cell International (CCEL) is a pioneer and leader in stem cell banking. They provide cord blood stem cell collection and cryopreservation services for family banking. The chart shows the average index for the segment, helping investors assess how well CCEL performs in its bioinsurance niche compared to the average.
The AKIM Index for the overall market
Cryo-Cell International is a cord blood stem cell bank. It provides storage services for families. This chart, reflecting the market average, is a backdrop. It helps assess how this "protective" consumer service, dependent on fertility, compares to general macroeconomic fluctuations.
